Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.3 (
glutathione synthetase
)
678
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Damage to the retinal pigment epithelium (RPE) is an early event in the pathogenesis of age-related macular degeneration (AMD).
X-box binding protein 1
(
XBP1
) is a key transcription factor that regulates endoplasmic reticulum (ER) homeostasis and cell survival. This study aimed to delineate the role of endogenous
XBP1
in the RPE. Our results show that in a rat model of light-induced retinal degeneration,
XBP1
activation was suppressed in the RPE/choroid complex, accompanied by decreased anti-oxidant genes and increased oxidative stress. Knockdown of
XBP1
by siRNA resulted in reduced expression of SOD1, SOD2, catalase, and
glutathione synthase
and sensitized RPE cells to oxidative damage. Using Cre/LoxP system, we generated a mouse line that lacks
XBP1
only in RPE cells. Compared to wildtype littermates, RPE-
XBP1
KO mice expressed less SOD1, SOD2, and catalase in the RPE, and had increased oxidative stress. At age 3 months and older, these mice exhibited apoptosis of RPE cells, decreased number of cone photoreceptors, shortened photoreceptor outer segment, reduced ONL thickness, and deficit in retinal function. Electron microscopy showed abnormal ultrastructure, Bruch's membrane thickening, and disrupted basal membrane infolding in
XBP1
-deficient RPE. These results indicate that
XBP1
is an important gene involved in regulation of the anti-oxidant defense in the RPE, and that impaired activation of
XBP1
may contribute to RPE dysfunction and cell death during retinal degeneration and AMD.
...
PMID:X-box binding protein 1 is essential for the anti-oxidant defense and cell survival in the retinal pigment epithelium. 2271 95